Safety of dermal fillers

Journal of Drugs in Dermatology

Volumn 11, Issue 9, 2012, Pages 1053-1058

  Luebberding, Stefanie ^a   Alexiades Armenakas, Macrene ^b  

^a Dermatology and Laser Surgery Center   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMAL FILLER; FILLER; HYALURONIC ACID; HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; AGING; AUTOLOGOUS FIBROBLAST CELL THERAPY; CELL THERAPY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMPLANT; REVIEW; SAFETY; THROMBOCYTE RICH PLASMA; WRINKLE;

BOTULINUM TOXINS; COSMETIC TECHNIQUES; HUMANS; LASER THERAPY; NEUROMUSCULAR AGENTS; REJUVENATION; SKIN AGING;

EID: 84867445893     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Lévêque JL. EEMCO guidance for the assessment of skin topography. The European Expert Group on Efficacy Measurement of Cosmetics and other Topical Products. J Eur Acad Dermatol Venereol 1999; 12(2): 103-114.
2. Cronin H, Draelos ZD. Top 10 botanical ingredients in 2010 anti-aging creams. J Cosmet Dermatol 2010; 9(3): 218-225.
3. Dulguerov N, D'Souza A. Update on treatment rationale and options for the ageing face. Curr Opin Otolaryngol Head Neck Surg 2011; 19(4): 269-275.
4. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J. Am. Acad. Dermatol. 2008; 58(5): 719-737. (Pubitemid 351509649)
5. Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ. A systematic review of dermal fillers for age-related lines and wrinkles. ANZ J Surg 2011; 81(1-2): 9-17.
6. Beasley KL, Weiss MA, Weiss RA. Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg 2009; 25(2): 86-94.
7. Kim J-E, Sykes JM. Hyaluronic acid fillers: history and overview. Facial Plast Surg 2011; 27(6): 523-528.
8. American Society Plastic Surgeons. Cosmetic Surgery National Data Bank. Available from: http://www.surgery.org/sites/default/files/ASAPS-2011-Stats.pdf. Accessed July 28, 2012.
9. Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg 2008; 34(3): 326-335. (Pubitemid 351316823)
10. U.S. Food and Drug Administration. Wrinkle Relief: Injectable Cosmetic Fillers. Available from: http://www.fda.gov/ForConsumers/ConsumerUpdates/ ucm049349.htm. Accessed July 15, 2012.
11. Glogau RG. Fillers: from the past to the future. Semin Cutan Med Surg 2012; 31(2): 78-87.
12. Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol 2008; 7(4): 251-258.
13. U.S. Food and Drug Administration. Available from: http://www.fda.gov/. Accessed July 15, 2012.
14. U.S. Food and Drug Administration. Approval Letter-Radiesse. Available from: http://www.accessdata.fda.gov/cdrh-docs/pdf5/P050037a.pdf. Accessed July 15, 2012.
15. Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004; 6(4): 223-226. (Pubitemid 40547028)
16. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg 2008; 34 Suppl 1S64-67.
17. Nguyen AT, Ahmad J, Fagien S, Rohrich RJ. Cosmetic medicine: facial resurfacing and injectables. Plast. Reconstr. Surg. 2012; 129(1): 142e-153e.
18. Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg 2009; 25(2): 95-99.
19. U.S. Food and Drug Administration. Approval Letter- Artefill. Available from: http://www.accessdata.fda.gov/cdrh-docs/pdf2/p020012a.pdf. Accessed July 15, 2012.
20. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29(6): 573-587. (Pubitemid 36702440)
21. U.S. Food and Drug Administration. Approval Letter-Laviv. Available from: http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ ApprovedProducts/ucm260486.htm. Accessed July 15, 2012.
22. Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg 1999; 1(3): 165-170.
23. Smith SR, Munavalli G, Weiss R, Maslowski JM, Hennegan KP, Novak JM. A Multicenter, Double-Blind, Placebo-Controlled Trial of Autologous Fibroblast Therapy (Azficel-T) for the Treatment of Nasolabial Fold Wrinkles [Internet]. 2012;
24. Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 2007; 33(3): 263-268. (Pubitemid 46328223)
25. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol 2011; 23(4): 424-431.
26. Cho JM, Lee YH, Baek R-M, Lee SW. Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice. J Plast Reconstr Aesthet Surg 2011; 64(2): e31-39.
27. Redaelli A, Romano D, Marcianó A. Face and neck revitalization with platelet-rich plasma (PRP): clinical outcome in a series of 23 consecutively treated patients. J Drugs Dermatol 2010; 9(5): 466-472.
28. Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Mol. Biol. Cell 2010; 21(11): 1783-1787.
29. Gir P, Oni G, Brown SA, Mojallal A, Rohrich RJ. Human adipose stem cells: current clinical applications. Plast. Reconstr. Surg. 2012; 129(6): 1277-1290.
30. Kim W-S, Park B-S, Sung J-H. Protective role of adipose-derived stem cells and their soluble factors in photoaging. Arch. Dermatol. Res. 2009; 301(5): 329-336.
31. Moseley TA, Zhu M, Hedrick MH. Adipose-derived stem and progenitor cells as fillers in plastic and reconstructive surgery. Plast. Reconstr. Surg. 2006; 118(3 Suppl): 121S-128S. (Pubitemid 44319097)
32. Kim W-S, Park B-S, Park S-H, Kim H-K, Sung J-H. Antiwrinkle effect of adipose-derived stem cell: activation of dermal fibroblast by secretory factors. J. Dermatol. Sci. 2009; 53(2): 96-102.
33. Cox SE, Adigun CG. Complications of injectable fillers and neurotoxins. Dermatol Ther 2011; 24(6): 524-536.
34. Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009; 35 Suppl 21672-1680.
35. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31(11 Pt 2): 1616-1625.
36. Vochelle D. The use of poly-L-lactic acid in the management of soft-tissue augmentation: a five-year experience. Semin Cutan Med Surg 2004; 23(4): 223-226. (Pubitemid 43180996)
37. Niamtu J 3rd. Complications in fillers and Botox. Oral Maxillofac Surg Clin North Am 2009; 21(1): 13-21.
38. Narins RS, Jewell M, Rubin M, Cohen J, Strobos J. Clinical conference: management of rare events following dermal fillers - focal necrosis and angry red bumps. Dermatol Surg 2006; 32(3): 426-434.
39. Friedman PM, Mafong EA, Kauvar ANB, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28(6): 491-494. (Pubitemid 34686633)
40. Narins RS, Bowman PH. Injectable skin fillers. Clin Plast Surg 2005; 32(2): 151-162. (Pubitemid 40462271)
41. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg 1998; 24(12): 1317-1325. (Pubitemid 29018221)
42. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 2004; 6(4): 234-239.
43. Lazzeri D, Agostini T, Figus M, Nardi M, Pantaloni M, Lazzeri S. Blindness following cosmetic injections of the face. Plast. Reconstr. Surg. 2012; 129(4): 995-1012.
44. Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PS. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg 2007; 33 Suppl 2S128-135.
45. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29(6): 588-595. (Pubitemid 36702442)
46. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast. Reconstr. Surg. 2005; 115(1): 282-289. (Pubitemid 40187829)
47. DeLorenzi C, Weinberg M, Solish N, Swift A. Multicenter study of the efficacy and safety of subcutaneous non-animal-stabilized hyaluronic acid in aesthetic facial contouring: interim report. Dermatol Surg 2006; 32(2): 205-211.
48. Engelhard P, Humble G, Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 2005; 7(3-4): 201-205. (Pubitemid 43111922)
49. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg 2008; 32(5): 753-756.
50. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast. Reconstr. Surg. 2006; 118(3 Suppl): 46S-54S. (Pubitemid 44319090)
51. Valantin M-A, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, Bousquet R, Katz P, Costagliola D, Katlama C. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003; 17(17): 2471-2477. (Pubitemid 38393319)
52. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg 2006; 25(3): 132-137. (Pubitemid 44572810)
53. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010; 30(2): 235-238.
54. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast. Reconstr. Surg. 2006; 118(3 Suppl): 22S-30S. (Pubitemid 44319087)
55. Salles AG, Lotierzo PH, Gemperli R, Besteiro JM, Ishida LC, Gimenez RP, Menezes J, Ferreira MC. Complications after polymethylmethacrylate injections: report of 32 cases. Plast. Reconstr. Surg. 2008; 121(5): 1811-1820. (Pubitemid 351642742)
56. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 Suppl 1S92-99.
57. Martínez-Zapata MJ, Martí-Carvajal A, Solà I, Bolibar I, Angel Expósito J, Rodriguez L, García J. Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion 2009; 49(1): 44-56.
58. Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol 2010; 9(1): 66-71.
59. Sclafani AP. Safety, efficacy, and utility of platelet-rich fibrin matrix in facial plastic surgery. Arch Facial Plast Surg 2011; 13(4): 247-251.
60. Cervelli V, Nicoli F, Spallone D, Verardi S, Sorge R, Nicoli M, Balzani A. Treatment of traumatic scars using fat grafts mixed with platelet-rich plasma, and resurfacing of skin with the 1540 nm nonablative laser. Clin. Exp. Dermatol. 2012; 37(1): 55-61.
61. Harris NL, Huffer WE, von Stade E, Larson AI, Phinney S, Purnell ML. The effect of platelet-rich plasma on normal soft tissues in the rabbit. J Bone Joint Surg Am 2012; 94(9): 786-793.
62. Locke M, Feisst V, Dunbar PR. Concise review: human adipose-derived stem cells: separating promise from clinical need. Stem Cells 2011; 29(3): 404-411.
63. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011; 17(1-2): 93-106.
64. Prantl L, Muehlberg F, Navone NM, Song Y-H, Vykoukal J, Logothetis CJ, Alt EU. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate 2010; 70(15): 1709-1715.
65. Yu JM, Jun ES, Bae YC, Jung JS. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008; 17(3): 463-473. (Pubitemid 351948199)
66. Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, Touil I, André M, Grolleau J-L, Péron J-M, Chavoin J-P, Bourin P, Pénicaud L, Casteilla L, Buscail L, Cordelier P. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE 2009; 4(7): e6278.
67. Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E, De Santis G, Spano C, Tagliazzucchi M, Barti-Juhasz H, Scarabelli L, Bambi F, Frassoldati A, Rossi G, Casali C, Morandi U, Horwitz EM, Paolucci P, Conte P, Dominici M. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res. 2010; 70(9): 3718-3729.